Diagnostic accuracy of placental growth factor (PIGF) in pre-eclampsia- A case control study

Background: Preeclampsia (PE) complicates 3~8% of all pregnancies. In developing countries, the perinatal and neonatal mortality rate due to PE is about 10% worldwide. Preeclampsia is characterized by decreasedmaternal circulating pro-angiogenicproteins like placental growth factor (PIGF), prior to...

Full description

Saved in:
Bibliographic Details
Main Authors: Sangappa Kashinakunti (Author), Basavaraj Devaranavadagi (Author), Ashalata Mallapur (Author)
Format: Book
Published: Wolters Kluwer Medknow Publications, 2020-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_aa6942a7a6e245429a045c7b0bd41ee9
042 |a dc 
100 1 0 |a Sangappa Kashinakunti  |e author 
700 1 0 |a Basavaraj Devaranavadagi  |e author 
700 1 0 |a Ashalata Mallapur  |e author 
245 0 0 |a Diagnostic accuracy of placental growth factor (PIGF) in pre-eclampsia- A case control study 
260 |b Wolters Kluwer Medknow Publications,   |c 2020-01-01T00:00:00Z. 
500 |a 2468-838X 
500 |a 2456-1975 
500 |a 10.4103/2468-838X.303775 
520 |a Background: Preeclampsia (PE) complicates 3~8% of all pregnancies. In developing countries, the perinatal and neonatal mortality rate due to PE is about 10% worldwide. Preeclampsia is characterized by decreasedmaternal circulating pro-angiogenicproteins like placental growth factor (PIGF), prior to clinical signs of PE, which is involved in its pathogenesis. Studies have demonstrated low PlGF as a PE predictorbutthe clinical utility of PlGF is not yet generally established andonly few studies have focused on neonatal outcomes. Objectives: To correlate the PIGF with severity of PE and to find out the best cut-off of PIGF for prediction of PEby ROC curve analysis and find association with neonatal outcome. Methods: The study was conducted tertiary care hospital North Karnataka. Forty singleton primigravidaPE patients diagnosed as per ACOG guide lines and 40 healthy pregnant were selected for the study. PIGF was estimated by ELISA method. Results: PIGF was significantly (p=0.034) higher in PE patients than controls and there was non-significant rise in mild PE than severe PE patients. Best cut-off value of PIGF was 105 pg/ml, with sensitivity 94.9% and specificity 67.6%, area under the curve was 0.845. Maternal serumPIGF≥ 105.00 pg/ml, there was significant (p=0.02) increase in neonatal birth weight (2.78±0.66 Kg). Conclusion: PIGF cut-off value 105 pg/ml can be used as predictor ofpreeclampsia andneonatal birth weight (2.78±0.66 Kg). 
546 |a EN 
690 |a preeclampsia 
690 |a placental growth factor 
690 |a neonate 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n BLDE University Journal of Health Sciences, Vol 5, Iss 3, Pp 31-32 (2020) 
787 0 |n http://www.bldeujournalhs.in/article.asp?issn=2468-838X;year=2020;volume=5;issue=3;spage=31;epage=32;aulast=Kashinakunti;type=0 
787 0 |n https://doaj.org/toc/2468-838X 
787 0 |n https://doaj.org/toc/2456-1975 
856 4 1 |u https://doaj.org/article/aa6942a7a6e245429a045c7b0bd41ee9  |z Connect to this object online.